USPTO serial 98256814
EISAI
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SWEENEY, MOLLY B
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with EISAI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Caroline H. Mead
Caroline H. Mead SQUIRE PATTON BOGGS (US) LLP550 California Street, Suite 1100SAN FRANCISCO, CA 94104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for treatment of oncological diseases, cancer, and tumors; pharmaceuticals for treatment of neurological diseases, Alzheimer's Disease, cognitive impairment, dementia, and epilepsy; pharmaceuticals for treatment of insomnia and other sleep disorders | ACTIVE | — |
| 009 | Downloadable mobile applications and computer software for providing information on health and wellness; Downloadable mobile applications and computer software for analyzing and evaluation of cognitive functions; Downloadable mobile applications and computer software for recording, storing and transmitting personal information, health management data, daily life data and medical data; Downloadable mobile applications and computer software for electronical interaction between doctors, medical care centers, healthcare professionals and patients; Downloadable mobile applications and computer software for patient monitoring and compliance management; Downloadable mobile applications and computer software for supporting patients and their care partners; Downloadable electronic publications in the nature of booklets, workbooks, guides, pamphlets or brochures in the field of health and wellness; Downloadable electronic publications in the nature of booklets, workbooks, guides, pamphlets or brochures in the field of neurology, Alzheimer's disease and related disorders, cognitive impairment and dementia; Downloadable electronic publications in the nature of booklets, workbooks, guides, pamphlets or brochures in the field of oncology; Downloadable electronic publications in the nature of booklets, workbooks, guides, pamphlets or brochures in the field of insomnia and other sleep disorders | ACTIVE | — |
| 042 | Providing online non-downloadable computer programs on data networks for human health care; Providing online non-downloadable computer programs for analyzing and evaluation of cognitive functions; Providing online non-downloadable computer programs on data networks for recording, storing and transmitting personal information, health management data, daily life data and medical data; Providing online non-downloadable computer programs on data networks for electronical interaction between doctors, medical care centers, healthcare professionals and patients; Providing online non-downloadable computer programs on data networks for patient monitoring and compliance management; Providing online non-downloadable computer programs on data networks for supporting patients and their care partners; Scientific research, technological research, digital science research and medical research in the field of oncology, neurology, insomnia, and digital science-based solutions for predicting, protecting and promoting brain health | ACTIVE | — |
| 044 | Providing healthcare and medical information; Providing information in the fields of health and wellness; Providing medical and health care information and medical advice in connection with patients and relatives support and follow-up programs; Providing medical information and health care information and advice to improve understanding about pharmaceuticals and medical treatments by health care providers, patients, patients' families and hospitals; Providing medical information, health care information and medical advice to cope with the associated symptoms of diseases in the field of oncology, neurology and immunology; Consultancy and information services relating to medical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Eisai R&D Management Co., Ltd.
- Other trademarks owned by Eisai R&D Management Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EISAI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 7, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 7, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 6, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 23, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 16, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 16, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 16, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 4, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 3, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 3, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 3, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 7, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 26, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 26, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 31, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2024 | ALIE | ASSIGNED TO LIE | — |
| Jun 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 3, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 5, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 2, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 9, 2023 | NWAP | NEW APPLICATION ENTERED | — |